Henric Bjarke Net Worth & Insider Trades

Henric Bjarke - SVP, Inozyme Pharma, Inc

As of December 19, 2022

What is Henric Bjarke's Net Worth?

The current estimated net worth of Inozyme Pharma, Inc's SVP, Henric Bjarke, is estimated to be about $236.6K . Henric Bjarke owns about 105,441 units of Inozyme Pharma, Inc common stock. In the last 2 years at Inozyme Pharma, Inc, Henric Bjarke has sold an estimated value of $0 worth.

What is Henric Bjarke's Past Insider Trading?

Henric Bjarke's largest purchase order was 27,100 units , worth over $100K on April 20, 2022. In total, Henric Bjarke has made about 7 transactions over 2 years of their time at Inozyme Pharma, Inc. Henric Bjarke usually trades in December, July, March, February, April, January and October, with the busiest year in 2022. The most recent transaction was a purchase order of 21,500 units , worth over $29.88K on December 19, 2022.

Henric Bjarke

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was Henric Bjarke's Salary in 2020?

As SVP of Inozyme Pharma, Inc, Henric Bjarke has a total base salary of $389,782 . Henric Bjarke received compensation valued at about $1,083,847 in 2020 after becoming SVP. The vast majority of their compensation came in the form of option awards of $506,970 , other earnings, plans or compensations of $187,095 , and

What is Henric Bjarke's' Mailing Address?

  • Mailing address is One University Square Drive, Suite 280 Princeton NJ 08540 NJ

Inozyme Pharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Axel Bolte 2020 $440,099 - $4,584,236 $290,466 $40,833 $5,355,634
Axel Bolte 2019 $378,000 $179,313 $353,470 - $60,000 $970,783
Henric Bjarke 2020 $389,782 - $506,970 $187,095 - $1,083,847
Henric Bjarke 2019 $350,200 $99,201 $141,388 - - $590,789
Pedro Huertas 2020 $397,843 - $604,993 $159,137 - $1,161,973
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1693011/000119312521132657/d24332ddef14a.htm

What are Inozyme Pharma, Inc's Past Insider Trades?

Inozyme Pharma, Inc's most recent insider trade came on December 19, 2022 by Henric Bjarke who bought 21,500 units worth $29.88K . In the last 2 years, insiders at Inozyme Pharma, Inc have sold an estimated value of $7.88M and bought an estimated value of $90.96M worth of shares. Insider trading is most common in July, with the busiest year in 2020. The most active traders at the company are Axel Bolte, Chief Executive Officer,  Henric Bjarke, SVP,  and Robert Hopfner, Director .

Inozyme Pharma, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...